Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001995218-26-000004

Chief Executive Officer sold 10,173 shares at $6.38 ($64,924)

From the SEC's structured data for this filing

Trades in this filing

Townsend Richard Nolan · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-18 Sale : show line 1 in the form −10,173 $6.38 $64,924 392,483 D
Open-market sales · 10,173 sh · avg $6.38 · $64,924
Loading xslF345X05/form4-02202026_050203.xml…